Quote | Stevanato Group S.p.A. (NYSE:STVN)
Last: | $20.32 |
---|---|
Change Percent: | -0.15% |
Open: | $19.6 |
Close: | $20.32 |
High: | $20.89 |
Low: | $19.44 |
Volume: | 650,399 |
Last Trade Date Time: | 05/31/2024 03:00:00 am |
News | Stevanato Group S.p.A. (NYSE:STVN)
Cisterna’s site is the first to implement premium solutions outside the Group’s headquarters in Piombino Dese to meet the growing demand for biopharmaceuticals, such as GLP-1s in Europe. Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containme...
2024-05-29 02:16:04 ET Summary Stevanato revised its guidance for 2024 due to weaker-than-expected orders and clients' destocking activities. The company's Q1 results show decreased EBITDA and profit, causing investors to sell off shares. Here at the Lab, we remain confident i...
Message Board Posts | Stevanato Group S.p.A. (NYSE:STVN)
Subject | By | Source | When |
---|---|---|---|
$STVN $50 TARGET PRICE WOOHOOOOOO | weedtrader420 | investorshub | 09/04/2021 9:46:20 AM |
Picks and shovels! Love it! | Glider549 | investorshub | 08/12/2021 1:47:21 AM |
Owns 80% of the vaccine Bottling business | weedtrader420 | investorshub | 07/16/2021 5:30:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Stevanato Group S.p.A. Company Name:
STVN Stock Symbol:
NYSE Market:
Cisterna’s site is the first to implement premium solutions outside the Group’s headquarters in Piombino Dese to meet the growing demand for biopharmaceuticals, such as GLP-1s in Europe. Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containme...
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced today that its Board of Directors has appointed Franco Stevanato, a current director and the Exec...
-All Resolutions Proposed to Shareholders Passed- Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries today announced that all resolutions proposed ...